It’s called the “Marijuana 1-to-3 Act,” and it would reschedule marijuana from a Schedule I controlled substance to a less restricted Schedule III controlled substance.
In the U.S., drugs are classified into five different categories based on the “drug’s acceptable medical use and the drug’s abuse or dependency potential,” according to the Drug Enforcement Administration.
Schedule I drugs are the most restricted as they “have a high potential for abuse and the potential to create severe psychological and/or physical dependence,” the DEA website reads.
Marijuana is currently classified as Schedule I along with LSD, heroin and ecstasy. Drugs in this category are said to have “no currently accepted medical use.”
Steube’s bill, which was introduced in the House just more than a week ago, would drop marijuana to Schedule III — the same category as testosterone, ketamine and Tylenol with codeine.
The “Marijuana 1-to-3 Act” would allow researchers to access federal funds to determine marijuana’s medical value, according to a release from Steube’s office.
MORE: http://bit.ly/3jIBGp9
►Subscribe: https://on.wtsp.com/youtube
►Website: https://www.wtsp.com/
►Facebook: https://facebook.com/10TampaBay
►Twitter: https://twitter.com/10TampaBay